Shyamala C. Navada, MD, MSCR

Assistant Professor
Mount Sinai School of Medicine
Department of Medicine
Division of Hematology/Oncology
New York, New York

Dr. Shyamala Navada received her medical degree from the University of Illinois College of Medicine in Chicago, as well as a master’s of science in clinical research from Mount Sinai School of Medicine in New York City. She completed a medical residency at the University of Michigan Hospitals and a hematology/oncology fellowship at Mount Sinai School of Medicine. Dr. Navada is Assistant Professor at Mount Sinai School of Medicine, Department of Medicine, Division of Hematology/Oncology, she is also an Assistant Attending Physician at Mount Sinai Beth Israel.

Dr. Navada is board certified in hematology and medical oncology. Her academic career in clinical and translational research in myelodysplastic syndromes (MDS) focuses on designing early phase trials investigating the role of novel candidate drugs to improve the outcome of patients with MDS and acute myeloid leukemia (AML). Her clinical expertise is in the medical management of MDS AML, and she also manages patients with benign hematologic conditions, such as cytopenias. As a result of her academic and research activities, Dr. Navada has presented at national and international meetings, including the American Society of Hematology, International Bone Marrow Failure Disease Scientific Symposium, International Symposium on Myelodysplastic Syndromes, and the European Hematology Association Congress. In addition, she is the author/co-author of medical textbook chapters and articles in peer-reviewed journals, including The Journal of Clinical Investigation and Leukemia Research.

Last modified: March 6, 2020